View in EDS PDF Full Text

β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation.

Saved in:
Bibliographic Details
Title: β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation.
Authors: Mantuano, Paola1 (AUTHOR) paola.mantuano@uniba.it, Boccanegra, Brigida1 (AUTHOR) brigida.boccanegra@uniba.it, Conte, Elena1 (AUTHOR) elena.conte@uniba.it, De Bellis, Michela1 (AUTHOR) michela.debellis@uniba.it, Cirmi, Santa1 (AUTHOR) santa.cirmi@uniba.it, Sanarica, Francesca1 (AUTHOR) francesca.sanarica@uniba.it, Cappellari, Ornella1 (AUTHOR) ornella.cappellari@uniba.it, Arduino, Ilaria2 (AUTHOR) ilaria.arduino@uniba.it, Cutrignelli, Annalisa2 (AUTHOR) annalisa.cutrignelli@uniba.it, Lopedota, Angela Assunta2 (AUTHOR) angelaassunta.lopedota@uniba.it, Mele, Antonietta1 (AUTHOR) antonietta.mele@uniba.it, Denora, Nunzio2 (AUTHOR) nunzio.denora@uniba.it, De Luca, Annamaria1 (AUTHOR) annamaria.deluca@uniba.it
Source: Biomolecules (2218-273X). Nov2021, Vol. 11 Issue 11, p1742. 1p.
Database: Academic Search Ultimate
Description
ISSN:2218273X
DOI:10.3390/biom11111742